Deminor has opened registration for former institutional shareholders of Stada Arzneimittel AG who accepted the 2017 public takeover offer by Nidda Healthcare Holding AG, now Nidda Healthcare Holding GmbH.
Former Stada shareholders who tendered their shares in the 2017 offer at EUR 66.25 per share may be entitled to claim additional compensation of EUR 8.15 per share, plus statutory interest.
This follows two rulings of the German Supreme Court dated 23 May 2023.
Deminor is organising a fully funded opt in legal action in Germany against Nidda Healthcare Holding GmbH. The action will be managed by Deminor together with renowned German counsel. Participating investors will not be required to advance litigation costs and will not assume litigation risk. Deminor’s funding solution means that clients only pay a remuneration in case of a successful recovery.
Former shareholders may be eligible if they accepted Nidda’s public takeover offer and tendered Stada shares between 19 July 2017 and 1 September 2017 at EUR 66.25 per share.
If you are an institutional investor that accepted Nidda’s 2017 takeover offer for Stada shares and wish to check, free of charge and without obligation, whether you are eligible to join Deminor’s funded legal action, please contact Deminor and provide your trading data on an anonymised basis. Deminor will perform a preliminary eligibility check and estimate the potential recoverable amount.
